Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932

PURPOSE: AALL0932 evaluated two randomized maintenance interventions to optimize disease-free survival (DFS) while reducing the burden of therapy in children with newly diagnosed NCI standard-risk (SR) B-acute lymphoblastic leukemia (B-ALL). METHODS: AALL0932 enrolled 9,229 patients with B-ALL; 2,36...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Angiolillo, Anne L., Schore, Reuven J., Kairalla, John A., Devidas, Meenakshi, Rabin, Karen R., Zweidler-McKay, Patrick, Borowitz, Michael J., Wood, Brent, Carroll, Andrew J., Heerema, Nyla A., Relling, Mary V., Hitzler, Johann, Lane, Ashley R., Maloney, Kelly W., Wang, Cindy, Bassal, Mylène, Carroll, William L., Winick, Naomi J., Raetz, Elizabeth A., Loh, Mignon L., Hunger, Stephen P.
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer Health 2021
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274746/
https://ncbi.nlm.nih.gov/pubmed/33411585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00494
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars